JP2014520877A5 - - Google Patents

Download PDF

Info

Publication number
JP2014520877A5
JP2014520877A5 JP2014520691A JP2014520691A JP2014520877A5 JP 2014520877 A5 JP2014520877 A5 JP 2014520877A5 JP 2014520691 A JP2014520691 A JP 2014520691A JP 2014520691 A JP2014520691 A JP 2014520691A JP 2014520877 A5 JP2014520877 A5 JP 2014520877A5
Authority
JP
Japan
Prior art keywords
pml
protein
subject
group
jcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014520691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014520877A (ja
Filing date
Publication date
Priority claimed from EP11006031A external-priority patent/EP2548567A1/en
Application filed filed Critical
Publication of JP2014520877A publication Critical patent/JP2014520877A/ja
Publication of JP2014520877A5 publication Critical patent/JP2014520877A5/ja
Pending legal-status Critical Current

Links

JP2014520691A 2011-07-22 2012-07-23 ワクチン接種および診断適用におけるポリオーマウイルスjcペプチドおよびタンパク質 Pending JP2014520877A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11006031A EP2548567A1 (en) 2011-07-22 2011-07-22 Polyoma virus JC peptides and proteins in vaccination and diagnostic applications
EP11006031.6 2011-07-22
PCT/EP2012/064445 WO2013014134A2 (en) 2011-07-22 2012-07-23 Polyoma virus jc peptides and proteins in vaccination and diagnostic applications

Publications (2)

Publication Number Publication Date
JP2014520877A JP2014520877A (ja) 2014-08-25
JP2014520877A5 true JP2014520877A5 (cg-RX-API-DMAC7.html) 2015-09-10

Family

ID=46548481

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014520691A Pending JP2014520877A (ja) 2011-07-22 2012-07-23 ワクチン接種および診断適用におけるポリオーマウイルスjcペプチドおよびタンパク質

Country Status (12)

Country Link
US (1) US9738690B2 (cg-RX-API-DMAC7.html)
EP (2) EP2548567A1 (cg-RX-API-DMAC7.html)
JP (1) JP2014520877A (cg-RX-API-DMAC7.html)
KR (1) KR20140062702A (cg-RX-API-DMAC7.html)
CN (1) CN103826653A (cg-RX-API-DMAC7.html)
AU (1) AU2012288955B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014001516A2 (cg-RX-API-DMAC7.html)
CA (1) CA2842543A1 (cg-RX-API-DMAC7.html)
EA (1) EA201490322A1 (cg-RX-API-DMAC7.html)
HK (1) HK1198517A1 (cg-RX-API-DMAC7.html)
MX (1) MX2014000776A (cg-RX-API-DMAC7.html)
WO (1) WO2013014134A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150065367A1 (en) * 2011-12-12 2015-03-05 Janssen Diagnostics Bvba Polyomavirus peptide sequences
US10300116B2 (en) 2013-06-10 2019-05-28 Ansun Biopharma, Inc. Treatment for BK polyomavirus infection
US9931393B2 (en) 2013-12-20 2018-04-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunogenic JC polyomavirus compositions and methods of use
EP2926831A1 (en) * 2014-03-31 2015-10-07 Ruprecht-Karls-Universität Heidelberg CD8+ T-cell epitopes from polyomavirus capsid protein VP1 for vaccination
WO2016073595A1 (en) * 2014-11-05 2016-05-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services T cells and dendritic cells for polyomavirus therapy
WO2016104046A1 (ja) * 2014-12-22 2016-06-30 日東電工株式会社 透明導電性フィルム
IT201600083859A1 (it) * 2016-08-09 2018-02-09 Univ Degli Studi Di Ferrara Immunosaggio per l’identificazione di anticorpi contro il virus Polioma JC (JCPyV) mediante l’uso di peptidi sintetici.
CN113278634B (zh) 2020-11-16 2022-06-28 艾棣维欣(苏州)生物制药有限公司 一种预防和治疗默克尔细胞癌的新型疫苗

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3767755B2 (ja) 1995-06-23 2006-04-19 エーザイ株式会社 抗jcウイルス抗体
DE19543553B4 (de) 1995-11-22 2009-04-09 Deutsches Primatenzentrum Gmbh VP-Antigene des JC-Virus
DE10131145B4 (de) 2001-06-28 2005-07-14 Innovent E.V. Zusammensetzung zum zellspezifischen Transfer von Wirkstoffen
JP4840792B2 (ja) 2001-11-22 2011-12-21 独立行政法人科学技術振興機構 JCウイルスagnoを対象としたPMLの治療
AU2003238008A1 (en) 2002-06-12 2003-12-31 Temple University Of The Commonwealth System Of Higher Education Method of cell growth inhibition with agnoprotein
JP2005341864A (ja) 2004-06-02 2005-12-15 Japan Science & Technology Agency Jcウイルスの粒子形成阻害剤
US7468186B2 (en) * 2005-07-22 2008-12-23 City Of Hope Polyomavirus cellular epitopes and uses therefor
US20080057079A1 (en) 2006-08-31 2008-03-06 Baylor Research Institute JC Virus Vaccine
CN100595765C (zh) * 2008-06-30 2010-03-24 腾讯科技(深圳)有限公司 基于媒体播放器的关键词内容发布方法及系统
AU2010210979B2 (en) * 2009-02-05 2015-12-10 Biogen Ma Inc. Methods for the detection of JC polyoma virus
WO2010099205A1 (en) 2009-02-24 2010-09-02 The Trustees Of The University Of Pennsylvania Methods for treating progressive multifocal leukoencephalopathy (pml)
EP2226392A1 (en) * 2009-03-03 2010-09-08 Assistance Publique - Hôpitaux de Paris Method for detecting JCV infection
WO2011124652A1 (en) * 2010-04-08 2011-10-13 Fondazione Centro San Raffaele Del Monte Tabor Immunodominant peptide of polyomavirus jc and uses thereof

Similar Documents

Publication Publication Date Title
Akbari et al. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
US10722562B2 (en) Combinatorial analysis and repair
Martins et al. Adjuvant-enhanced CD4 T cell responses are critical to durable vaccine immunity
JP2014534202A5 (cg-RX-API-DMAC7.html)
EP3851120A1 (en) Immunogen for broad-spectrum influenza vaccine and application thereof
JP2011250797A5 (cg-RX-API-DMAC7.html)
JP2018523668A5 (cg-RX-API-DMAC7.html)
Baydemir et al. Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery
WO2012069568A3 (en) Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
JP2019520061A5 (cg-RX-API-DMAC7.html)
WO2015095167A3 (en) Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon
JP2021169495A (ja) 酵母細胞壁粒子を用いたワクチン送達系
Helou et al. Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis
JP2015514115A5 (cg-RX-API-DMAC7.html)
JP2014139185A5 (cg-RX-API-DMAC7.html)
AU2012288955A1 (en) Polyoma virus JC peptides and proteins in vaccination and diagnostic applications
JP2006502228A5 (cg-RX-API-DMAC7.html)
Esposito et al. Herpes zoster prevention: a difficult problem to solve
RU2014140731A (ru) Варианты гемагглютинина и нейраминидазы гриппа
JP2017516752A5 (cg-RX-API-DMAC7.html)
Maurya et al. Novel stem cells and nucleic acid-based vaccine trials against viral outbreak: a systematic evaluation during COVID-2019 pandemic
Semakova et al. Adjuvant technologies in the construction of advanced vaccines
Płaszczyńska et al. Regression of common viral warts after ChAdOx1‐S COVID‐19 vaccine
JP2017502058A5 (cg-RX-API-DMAC7.html)
O’Shea et al. Changing face of vaccination in immunocompromised hosts